UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Are made-in-Korea Botox products smuggled into China?
by Nam Doo-hyun
2017-07-10 16:25
Breast cancer therapy Ibrance likely to get insurance benefit
by Nam Doo-hyun
2017-07-07 14:26
Is it necessary to write ‘MD’ in license for herb doctors?
by Nam Doo-hyun
2017-07-06 17:23
Smaller firms lead domestic stem cell market
by Nam Doo-hyun
2017-07-05 13:49
Pompous start, poor showing: R&D report card of oriental medicine
by Nam Doo-hyun
2017-07-05 12:00
라인
A letter to Pfizer CEO Michael Goettler
by Nam Doo-hyun
2017-07-04 18:57
KISTI present ways to sharpen competitiveness of precision medicine
by Nam Doo-hyun
2017-06-23 13:35
Why Roche Korea can’t unveil research results of new lung cancer therapy?
by Nam Doo-hyun
2017-06-22 16:36
‘Korea needs to develop biomarkers for personalized medical services’
by Nam Doo-hyun
2017-06-22 13:24
Sanofi fuels competition in 4-strain flu vaccine market
by Nam Doo-hyun
2017-06-21 11:36
라인
Kwangdong tops pharmaceuticals’ 1Q sales list of health food
by Nam Doo-hyun
2017-06-20 18:47
'Bio ventures are for developing new drugs, not making cosmetics'
by Nam Doo-hyun
2017-06-19 14:47
Experts call for separate organ to develop bio drugs
by Nam Doo-hyun
2017-06-15 13:12
New government set to streamline healthcare R&D projects
by Nam Doo-hyun
2017-06-15 11:05
Pharmaceutical industry wants to use medical big data at public organizations
by Nam Doo-hyun
2017-06-14 15:46
라인
Nation needs to develop new drugs to treat senile eye diseases
by Nam Doo-hyun
2017-06-12 12:28
Regulators deem Pfizer’s price for cancer therapy too high
by Nam Doo-hyun
2017-06-09 17:31
‘Break global makers’ monopoly on radiotherapy device market’
by Nam Doo-hyun
2017-06-08 17:30
Biogen to enter Korean market with new therapy
by Nam Doo-hyun
2017-06-07 17:40
Approvals soar for telemedicine SW, equipment
by Nam Doo-hyun
2017-06-05 17:18
-
이전
11
12
13
14
15
16
17
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top